Nevro Corp (NVRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 93,571 | 82,148 | 107,944 | 95,630 | 96,080 |
| Cost of Goods | 29,628 | 28,939 | 31,790 | 28,382 | 28,159 |
| Gross Profit | 63,943 | 53,209 | 76,154 | 67,248 | 67,921 |
| Operating Expenses | 91,131 | 96,402 | 85,547 | 76,867 | 76,281 |
| Operating Income | -26,560 | -42,254 | -8,603 | -9,237 | -8,201 |
| Interest Expense | 2,710 | 2,688 | 2,642 | 2,622 | 2,579 |
| Other Income | 1,607 | 1,206 | 1,129 | 1,145 | 543 |
| Pre-tax Income | -27,663 | -43,736 | -10,116 | -10,714 | -10,237 |
| Income Tax | 358 | 340 | -509 | 551 | 383 |
| Net Income Continuous | -28,021 | -44,076 | -9,607 | -11,265 | -10,620 |
| Net Income | $-28,021 | $-44,076 | $-9,607 | $-11,265 | $-10,620 |
| EPS Basic Total Ops | -0.91 | -1.45 | -0.33 | -0.37 | -0.35 |
| EPS Basic Continuous Ops | -0.91 | -1.45 | -0.32 | -0.37 | -0.35 |
| EPS Diluted Total Ops | -0.91 | -1.45 | -0.33 | -0.37 | -0.35 |
| EPS Diluted Continuous Ops | -0.91 | -1.45 | -0.32 | -0.37 | -0.35 |
| EBITDA(a) | $-25,224 | $-41,137 | $-8,255 | $-8,480 | $-7,449 |